Author:
Sicoe Isabela-Carina,Orban Emese,Moldovan Iuliu
Reference5 articles.
1. Brotherton JML. Impact of HPV vaccination: Achievements and future challenges. Papillomavirus Res. 2019;7:138-140.
2. Vichnin M, Bonanni P, Klein NP, et al. An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015. Pediatr Infect Dis J. 2015;34(9):983-991.
3. Lake PW, Kasting ML, Christy SM, Vadaparampil ST. Provider perspectives on multilevel barriers to HPV vaccination. Hum Vaccin Immunother. 2019;15(7-8):1784-1793.
4. Gilkey MB, Calo WA, Marciniak MW, Brewer NT. Parents who refuse or delay HPV vaccine: Differences in vaccination behavior, beliefs, and clinical communication preferences. Hum Vaccin Immunother. 2017;13(3):680-686.
5. Meites E, et al. Human Papillomavirus. In: Hall E, Wodi AP, Hamborsky J, Morelli V, Schillie S (Eds). Epidemiology and prevention of vaccine-preventablediseases. 14th ed. Washington: D.C. Public Health Foundation, 2021.